Lymph node staging in non-small-cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2142-2149

  Vansteenkiste, Johan F ^a   Stroobants, Sigrid G ^a   De Leyn, Paul R ^a   Dupont, Patrick J ^a   Bogaert, Jan ^a   Maes, Alex ^a   Deneffe, Georges J ^a   Nackaerts, Kris L ^a   Verschakelen, Johny A ^a   Lerut, Tony E ^a   Mortelmans, Luc A ^a   Demedts, Maurits G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDIASTINOSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; THORACOTOMY;

EID: 0031779919     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2142     Document Type: Article

References (35)

1. McLoud TC, Bourgouin PM, Greenberg RW, et al: Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 182:319-323, 1992
2. Webb WR, Gatsouris S, Zerhouni EA, et al: CT and MR imaging in staging non-small-cell bronchogenic carcinoma: Report of the Radiology Diagnostic Oncology Group. Radiology 178:705-713, 1991
3. Dillemans B, Deneffe G, Verschakelen J, et al: Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small-cell lung cancer. Eur J Cardiothorac Surg 8:37-42, 1994
4. Nolop KB, Rhodes CG, Brudin LH, et al: Glucose utilization in vivo by human pulmonary neoplasms. Cancer 60:2682-2689, 1987
5. Nelson CA, Wang JQ, Leav I, et al: The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models. Nucl Med Biol 23:553-541, 1996
6. Wahl R, Hutchins G, Bushsboaum D, et al: F-18 fluoro deoxyglucose uptake into human tumor xenografts. Cancer 67:1544-1550, 1991
7. Dewan N, Gupta N, Redepenning L, et al: Diagnostic efficiency of PET-FDG imaging in solitary pulmonary nodules. Chest 104:997-1002, 1993
8. Knight SB, Delbeke D, Stewart JR, et al: Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 109:982-988, 1996
9. Dewan NA, Reeb SD, Gupta NK, et al: PET-FDG imaging and transthoracic needle aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest 108:441-446, 1995
10. Patz EF, Lowe VJ, Hoffman JM, et al: Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188:487-490, 1993
11. Rege SD, Hoh CK, Glaspy JA, et al: Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 72:82-90, 1993
12. Kubota K, Matsuzawa T, Fujiwara T, et al: Differential diagnosis of lung tumor with positron emission tomography: A prospective study. J Nucl Med 31:1927-1932, 1990
13. Wahl RL, Quint LE, Greenough RL, et al: Staging of mediastinal non-small-cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. Radiology 191:371-377, 1994
14. Goldstraw P, Bureau G, Cullen M, et al: Pretreatment minimal staging for non-small-cell lung cancers: A consensus report. Lung Cancer 7:7-9, 1991
15. Naruke T, Suemasu K, Ishikawa S: Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Surg 76:832-837, 1978
16. Woodard HQ, Bigler RE, Freed B, et al: Expression of tissue isotope distribution. J Nucl Med 16:958-959, 1975
17. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982
18. Beck J: Likelihood ratios: Another enhancement of sensitivity and specificity. Arch Pathol Lab Med 110:685-686, 1986
19. Galen PS: Predictive values of laboratory tests. Am J Cardiol 36:536-538, 1975
20. Carlens E: Mediastinoscopy: A method for inspection and tissue biopsy in the superior mediastinum. Dis Chest 36:343-347, 1959
21. McNeil TM, Chamberlain JM: Diagnostic anterior mediastinotomy. Ann Thorac Surg 2:532-539, 1966
22. Scott WJ, Schwabe JL, Gupta NC, et al: Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group. Ann Thorac Surg 58:698-703, 1994
23. Valk PE, Pounds TR, Hopkins DM, et al: Staging non-small-cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 60:1573-1581, 1995
24. Chin R, Ward R, Keyes JW, et al: Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 152:2090-2096, 1995
25. Bury T, Dowlati A, Paulus P, et al: Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 9:410-414, 1996
26. Patz EF, Lowe VJ, Goodman PC, et al: Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. Chest 108:1617-1621, 1995
27. Sazon DA, Santiago SM, Soo Hoo GW, et al: Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 153:417-421, 1996
28. Sasaki M, Ichiya Y, Kuwabara Y, et al: The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small-cell lung cancer: A comparative study with X-ray computed tomography. Eur J Nucl Med 23:741-747, 1996
29. Bury T, Dowlati A, Paulus P, et al: Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography. Eur J Nucl Med 23:204-206, 1996
30. Steinert HC, Hauser M, Allemann F, et al: Non-small-cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 202:441-446, 1997
31. Scott WJ, Gobar LS, Terry JD, et al: Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 111:642-648, 1996
32. Lowe VJ, Hoffman JM, DeLong DM, et al: Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. J Nucl Med 35:1771-1776, 1994
33. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al: Survival and prognostic factors in resected N2 non-small-cell lung cancer: A study of 140 cases. The Leuven Lung Cancer Group. Ann Thorac Surg 63:1441-1450, 1997
34. Nohl-Oser HC: An investigation of the anatomy of the lymphatic drainage of the lungs as shown by the lymphatic spread of bronchial carcinoma. Ann R Coll Surg Engl 51:157-176, 1972
35. Gambhir SS, Hoh CK, Phelps ME, et al: Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 37:1428-1436, 1996